Stock Track | CapsoVision (CV) Surges 7.14% After Hours Following Successful IPO and Strong Market Debut

Stock Track

Jul 03, 2025

CapsoVision, Inc. (NASDAQ: CV) continued its impressive market performance with a 7.14% surge in after-hours trading on Wednesday, building upon its strong debut as a publicly traded company. This latest jump comes on the heels of the medical technology firm's successful initial public offering (IPO) and a notable 6.90% gain during regular trading hours.

The company's IPO, which priced shares at $5 each, aimed to raise approximately $27.5 million in gross proceeds. CapsoVision offered 5.5 million shares to the public, with trading commencing on the Nasdaq under the ticker symbol "CV". The enthusiastic market reception during regular trading hours appears to have carried over into the after-hours session, reflecting sustained investor optimism about CapsoVision's prospects in the medical technology sector.

As CapsoVision prepares for its first full day of trading on Thursday, when the IPO is expected to officially close, the strong after-hours performance suggests continued investor interest. The company has also granted its underwriters a 30-day option to purchase up to an additional 825,000 shares, which could potentially increase the total funds raised. This successful market debut and the subsequent after-hours surge may set a positive tone for CapsoVision's future in the public markets, as investors appear eager to support innovative companies in the evolving medical technology landscape.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1120075448"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120075448\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120075448?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-03 04:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120075448","market":"sg","top_or_hot":-1,"title":"Stock Track | CapsoVision (CV) Surges 7.14% After Hours Following Successful IPO and Strong Market Debut","media":"Stock Track","content":"<p>CapsoVision, Inc. (NASDAQ: CV) continued its impressive market performance with a 7.14% surge in after-hours trading on Wednesday, building upon its strong debut as a publicly traded company. This latest jump comes on the heels of the medical technology firm's successful initial public offering (IPO) and a notable 6.90% gain during regular trading hours.</p>\n\n<p>The company's IPO, which priced shares at $5 each, aimed to raise approximately $27.5 million in gross proceeds. CapsoVision offered 5.5 million shares to the public, with trading commencing on the Nasdaq under the ticker symbol \"CV\". The enthusiastic market reception during regular trading hours appears to have carried over into the after-hours session, reflecting sustained investor optimism about CapsoVision's prospects in the medical technology sector.</p>\n\n<p>As CapsoVision prepares for its first full day of trading on Thursday, when the IPO is expected to officially close, the strong after-hours performance suggests continued investor interest. The company has also granted its underwriters a 30-day option to purchase up to an additional 825,000 shares, which could potentially increase the total funds raised. This successful market debut and the subsequent after-hours surge may set a positive tone for CapsoVision's future in the public markets, as investors appear eager to support innovative companies in the evolving medical technology landscape.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CapsoVision (CV) Surges 7.14% After Hours Following Successful IPO and Strong Market Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CapsoVision (CV) Surges 7.14% After Hours Following Successful IPO and Strong Market Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-07-03 04:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CapsoVision, Inc. (NASDAQ: CV) continued its impressive market performance with a 7.14% surge in after-hours trading on Wednesday, building upon its strong debut as a publicly traded company. This latest jump comes on the heels of the medical technology firm's successful initial public offering (IPO) and a notable 6.90% gain during regular trading hours.</p>\n\n<p>The company's IPO, which priced shares at $5 each, aimed to raise approximately $27.5 million in gross proceeds. CapsoVision offered 5.5 million shares to the public, with trading commencing on the Nasdaq under the ticker symbol \"CV\". The enthusiastic market reception during regular trading hours appears to have carried over into the after-hours session, reflecting sustained investor optimism about CapsoVision's prospects in the medical technology sector.</p>\n\n<p>As CapsoVision prepares for its first full day of trading on Thursday, when the IPO is expected to officially close, the strong after-hours performance suggests continued investor interest. The company has also granted its underwriters a 30-day option to purchase up to an additional 825,000 shares, which could potentially increase the total funds raised. This successful market debut and the subsequent after-hours surge may set a positive tone for CapsoVision's future in the public markets, as investors appear eager to support innovative companies in the evolving medical technology landscape.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CV","symbol_name":"CapsoVision, Inc.","start_time":0,"source_url":"","article_id":"1120075448","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120075448","pubTimestamp":1751488587,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"CapsoVision, Inc.  continued its impressive market performance with a 7.14% surge in after-hours trading on Wednesday, building upon its strong debut as a publicly traded company. This latest jump comes on the heels of the medical technology firm's successful initial public offering  and a notable 6.90% gain during regular trading hours.As CapsoVision prepares for its first full day of trading on Thursday, when the IPO is expected to officially close, the strong after-hours performance suggests ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CV":"CapsoVision, Inc."},"translate_title":"股票跟踪CapsoVision(CV)在成功IPO和强劲的市场首次亮相后盘后飙升7.14%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CV":1},"content_text":"CapsoVision, Inc. (NASDAQ: CV) continued its impressive market performance with a 7.14% surge in after-hours trading on Wednesday, building upon its strong debut as a publicly traded company. This latest jump comes on the heels of the medical technology firm's successful initial public offering (IPO) and a notable 6.90% gain during regular trading hours.\nThe company's IPO, which priced shares at $5 each, aimed to raise approximately $27.5 million in gross proceeds. CapsoVision offered 5.5 million shares to the public, with trading commencing on the Nasdaq under the ticker symbol \"CV\". The enthusiastic market reception during regular trading hours appears to have carried over into the after-hours session, reflecting sustained investor optimism about CapsoVision's prospects in the medical technology sector.\nAs CapsoVision prepares for its first full day of trading on Thursday, when the IPO is expected to officially close, the strong after-hours performance suggests continued investor interest. The company has also granted its underwriters a 30-day option to purchase up to an additional 825,000 shares, which could potentially increase the total funds raised. This successful market debut and the subsequent after-hours surge may set a positive tone for CapsoVision's future in the public markets, as investors appear eager to support innovative companies in the evolving medical technology landscape.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}